http://rdf.ncbi.nlm.nih.gov/pubchem/reference/34709117

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, Non-U.S. Gov't
issn 1549-9634
pageRange 102666-
publicationName Nanomedicine : nanotechnology, biology, and medicine
startingPage 102666
bibliographicCitation Shi W, Wan X, Wang Y, He J, Huang X, Xu Y, Zhang W, Chen R, Wang L, Zheng R, Ma L, Li X, Xu L, Zha X, Wang J. Nanoparticle albumin-bound paclitaxel-based neoadjuvant regimen: A promising treatment option for HER2-low-positive breast cancer. Nanomedicine: Nanotechnology, Biology and Medicine. 2023 Apr;49():102666. doi: 10.1016/j.nano.2023.102666.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_431663fc006b6bf86e5841a6b621d793
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b57fd85599b3988200425bc2049694bd
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_006c566c4888e117a681461adb4a60a2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_303ead1a68e2c3b241800d8c935ec5fe
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_302d8d5c22d0fb4516f25df7693b6c34
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_45618c44216143e7a8299fb837357b66
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8a8ec90887ddfec272ed1e930b827084
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d6a7f1f576d5fa77da23a24c28cbbe9b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c4df4825ad5ce01a1c2f18382d1cfe7b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_da3adc34c73ca2cc3438ca09b4e6e0c6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_401687487b9ef1195ae2557f34a72970
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5c3786a4ceb5e110688595bfec1a5c91
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_79e1f9d098f77bf0c057a1f0f26641f9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_25cee8b9fed57aaa3c8205c8039d381b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cedea4c53b3462efc96d5f23d7101323
date 202304
identifier https://pubmed.ncbi.nlm.nih.gov/36889422
https://doi.org/10.1016/j.nano.2023.102666
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/32817
https://portal.issn.org/resource/ISSN/1549-9634
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Nanoparticle albumin-bound paclitaxel-based neoadjuvant regimen: A promising treatment option for HER2-low-positive breast cancer
discusses http://id.nlm.nih.gov/mesh/M0028048
http://id.nlm.nih.gov/mesh/M0005485
http://id.nlm.nih.gov/mesh/M0000629
http://id.nlm.nih.gov/mesh/M000602078
http://id.nlm.nih.gov/mesh/M0184558
http://id.nlm.nih.gov/mesh/M0023488
http://id.nlm.nih.gov/mesh/M0026156
http://id.nlm.nih.gov/mesh/M0012577
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D001943Q000473
http://id.nlm.nih.gov/mesh/D053758
hasSubjectTerm http://id.nlm.nih.gov/mesh/D000068196Q000627
http://id.nlm.nih.gov/mesh/D003520Q000627
http://id.nlm.nih.gov/mesh/D000971Q000627
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D015251Q000627
http://id.nlm.nih.gov/mesh/D008070
http://id.nlm.nih.gov/mesh/D018719Q000378
http://id.nlm.nih.gov/mesh/D017239Q000627
http://id.nlm.nih.gov/mesh/D000077143Q000627
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D020360
http://id.nlm.nih.gov/mesh/D016896
http://id.nlm.nih.gov/mesh/D000418
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36314
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148124
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID41867
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2907
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_73717aafac1e7701dab0fa02b8936926
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_43830973f74de180729ad1e755d592ad

Showing number of triples: 1 to 61 of 61.